(Q41663257)

6 October 2017

title

Dual Effect of Lovastatin and Simvastatin on LDL-Macrophage Interaction (English)

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

18 November 2022

1 reference

M. Aviram

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1764540

18 November 2022

S. Keidar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1764540

18 November 2022

G. J. Brook

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1764540

18 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1764540

18 November 2022

publication date

1 October 1991

1 reference

full work available at URL

6 October 2017

https://www.degruyter.com/document/doi/10.1515/cclm.1991.29.10.657/pdf

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies

18 November 2022

published in

1 reference

6 October 2017

volume

29

1 reference

6 October 2017

issue

10

1 reference

6 October 2017

page(s)

657-664

1 reference

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

6 October 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance

18 November 2022

2

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia

18 November 2022

3

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Rational therapy of familial hypercholesterolemia

18 November 2022

5

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients

18 November 2022

6

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Comparative pharmacokinetics and pharmacodynamics of pravastatin and lovastatin.

18 November 2022

7

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Separation of apolipoproteins by an acrylamide-gradient sodium dodecyl sulfate gel electrophoresis system

18 November 2022

9

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Protein measurement with the Folin phenol reagent

18 November 2022

10

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Effects of fat level, feeding period, and source of fat on lipid fluidity and physical state of rabbit plasma lipoproteins

18 November 2022

13

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie

18 November 2022

14

27

3

Aviram M.

1989

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Vastatins inhibit cholesterol ester accumulation in human monocyte-derived macrophages

18 November 2022

17

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

18 November 2022

18

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

18 November 2022

19

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

Platelet secretory products increase low density lipoprotein oxidation, enhance its uptake by macrophages, and reduce its fluidity.

18 November 2022

21

1 reference

https://api.crossref.org/works/10.1515/CCLM.1991.29.10.657

18 November 2022

Identifiers

0 references

1 reference